1
|
Kus T, Aktas G, Kalender M, Sevinc A, Camci C. P53 and ERCC1 gene polymorphisms can predict the recurence risk of breast cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw364.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
2
|
Kalender M, Bulbul F, Aktas G, Kus T, Okyar B, Balakan O, Camci C. Awareness of cancer diagnosis in Turkish patients can increase anxiety and depression: is it true? Ann Oncol 2016. [DOI: 10.1093/annonc/mdw390.72] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
3
|
Kalender ME, Cakir M, Ergun S, Oztuzcu S, Cengiz B, Ulasli M, Sevinc A, Camci C. Abstract P6-08-08: Expression and role of ING3 gene in breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p6-08-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Inhibitor of growth (ING) tumor suppressor gene family has been discovered over the past decade and five different genes have been identified from ING1 to ING5. They have some functions like cell transcription regulation, cell cycle control, DNA repair and apoptosis. Because of the fact that ING3 gene expression has not been studied in breast cancer so far, we aimed to determine whether there was a relationship between ING3 gene expression and breast cancer prognostic factors.
Methods: 46 female breast cancer patients in different stages were enrolled to our study. ING3 gene expressions obtained from tumoral and healthy breast tissue samples of patients were evaluated together with pathological and histological parameters.
Results: The median age of the patients was 49 years. ING3 expression rate has been significantly higher in the tumor tissue compared to normal tissue and was statistically significant (p=0.001). In estrogen receptor (ER) and progesterone receptor (PR) positive patients, gene expression ratio was significantly higher than negative ones (p<0.001 and p<0.001, respectively). ING3 expression in tumor tissues of the patients with advanced disease (stage 3-4) was detected higher than ones with early stage disease and it was found to be statistically significant at the border (p=0.048). Moreover, there were no significant changes when ING3 gene expressions were compared with c-erbB2 (Receptor tyrosine-protein kinase erbB-2) status and tumor grade (p> 0.05).
Conclusions: This study was the first study on ING3 gene expression in breast cancer. ING3 gene expression has been shown to be associated with the receptor positivity and advanced stage disease. Further studies should be conducted on the prognostic significance of ING3 gene in breast cancer.
Citation Format: Kalender ME, Cakir M, Ergun S, Oztuzcu S, Cengiz B, Ulasli M, Sevinc A, Camci C. Expression and role of ING3 gene in breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-08-08.
Collapse
Affiliation(s)
- ME Kalender
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - M Cakir
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - S Ergun
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - S Oztuzcu
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - B Cengiz
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - M Ulasli
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - A Sevinc
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| | - C Camci
- Gaziantep University Medical Faculty, Gaziantep, Turkey; Faculty of Medicine, Gaziantep University, Gaziantep, Turkey; Gaziantep University, Gaziantep, Turkey; Gazi University, Ankara, Turkey
| |
Collapse
|
4
|
Ayten R, Aygen E, Cerrahoglu YZ, Camci C, Ilhan YS, Girgin M, Ilhan N, Ozercan IH. Effects of Copper, Zinc, and Vitamin Complex (Cernevit®) on Hepatic Healing in Rats Experimentally Subjected to Blunt Hepatic Trauma. Indian J Surg 2015; 77:1045-9. [PMID: 27011508 PMCID: PMC4775563 DOI: 10.1007/s12262-014-1128-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2014] [Accepted: 06/16/2014] [Indexed: 10/25/2022] Open
Abstract
Solid organ injuries following blunt trauma are frequently encountered. The use of non-operative approach is gradually increasing. Thus, research on the methods that could enhance healing in solid organ injuries is in progress. Agents known to have antioxidant property were used after an experimentally induced blunt hepatic trauma. Thirty-two Wistar albino rats weighing 200 g were dropped from a height of 40 cm on to the right upper abdominal quadrant to produce a grade II-III hepatic injury. Rats were divided into control, Zn-administered, Cu-administered, and vitamin complex-administered groups, with eight rats in each. Aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) levels were measured in the blood samples. The percentage of cells displaying Ki-67 nuclear staining was estimated. The sections were stained with hematoxylin and eosin and the degree of inflammation in the samples was semi-quantitatively assessed. Treatment with zinc, copper, and Cernevit® caused varying levels of decrease in AST, ALT, and LDH levels compared to the control group. Ki-67 positivity was significantly lower in group I compared with groups II and III (p = 0.002). Ki-67 positivity was significantly higher in group II compared to the other groups (p < 0.05). A marked improvement was observed in inflammation in group II. Copper and zinc treatment decreased inflammation as well as blood levels of AST and ALT, and enhanced the healing of traumatized hepatic tissue. However, Cernevit® reduced only the degree of inflammation.
Collapse
Affiliation(s)
- Refik Ayten
- />General Surgery Department, Firat University, Elazıg, Turkey
| | - Erhan Aygen
- />General Surgery Department, Firat University, Elazıg, Turkey
| | | | - Cemalettin Camci
- />General Surgery Department, Istanbul Bilim University, Elazıg, Turkey
| | | | - Mustafa Girgin
- />General Surgery Department, Firat University, Elazıg, Turkey
| | - Necip Ilhan
- />Biochemistry Department, Firat University, Elazıg, Turkey
| | | |
Collapse
|
5
|
Kalender M, Kuzhan A, Dirier A, Suner A, Camci C. 1544 The impact of smoking on smoking related cancer patients' relatives': Perspective in the Turkish society. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30634-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Sozucan Y, Kalender ME, Sari I, Suner A, Oztuzcu S, Arman K, Yumrutas O, Bozgeyik I, Cengiz B, Igci YZ, Balakan O, Camci C. TRP genes family expression in colorectal cancer. Exp Oncol 2015; 37:208-212. [PMID: 26422106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
UNLABELLED Colorectal cancer (CRC) is the most common cancer of the gastrointestinal tract. Different factors are responsible for the development of CRC. Transient Receptor Potential (TRP) which is an important component of calcium channel is associated with several pathological conditions like cancer, neurodegenerative and cardiovascular diseases. Thirty members of the family of TRP ion channel in mammals have been determined till now. The aim of this study is to investigate TRPM, TRPV and TRPC gene expression levels in tumor tissues of CRC patients and to analyze the relationship of expression in tumor tissue of CRC with other known prognostic factors. MATERIAL AND METHODS In this study, 93 CRC patients were included. The level of TRP gene expression in paraffin blocks of normal and cancerous colorectal tissue samples were studied at the level of mRNA with Real-time PCR. RESULTS The mRNA expression level of TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 genes in 37 female and 56 male patients diagnosed with CRC was revealed lower in tumor tissue as compared to normal tissue (p < 0.05). No statistically significant differences of mRNA expression levels of other TRP genes were found. CONCLUSIONS TRP gene family like TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 may be thought as potential genes contributing to tumorigenesis as their expression decreases in CRC as compared to normal tissues.
Collapse
Affiliation(s)
- Y Sozucan
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - M E Kalender
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - I Sari
- Department of Pathology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - A Suner
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - S Oztuzcu
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - K Arman
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - O Yumrutas
- Department of Medical Biology, Faculty of Medicine, Adiyaman University, Adiyaman TR-02040, Turkey
| | - I Bozgeyik
- Department of Medical Biology, Faculty of Medicine, Adiyaman University, Adiyaman TR-02040, Turkey
| | - B Cengiz
- Department of Medical Biology, Faculty of Medicine, Gazi University, Ankara TR-06560, Turkey
| | - Y Z Igci
- Department of Medical Biology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| | - O Balakan
- Department of Medical Oncology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras, TR-46100, Turkey
| | - C Camci
- Department of Medical Oncology, Faculty of Medicine, Gaziantep University, Gaziantep TR-27310, Turkey
| |
Collapse
|
7
|
Alptekin M, Eroglu S, Tutar E, Sencan S, Geyik MA, Ulasli M, Demiryurek AT, Camci C. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival. Tumour Biol 2015; 36:9209-13. [PMID: 26088448 DOI: 10.1007/s13277-015-3577-x] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 05/15/2015] [Indexed: 12/14/2022] Open
Abstract
Glioblastoma multiforme (GBM) is one of the most lethal forms of cancer in humans, with a median survival of 10 to 12 months. Glioblastoma is highly malignant since the cells are supported by a great number of blood vessels. Although new treatments have been developed by increasing knowledge of molecular nature of the disease, surgical operation remains the standard of care. The TRP (transient receptor potential) superfamily consists of cation-selective channels that have roles in sensory physiology such as thermo- and osmosensation and in several complex diseases such as cancer, cardiovascular, and neuronal diseases. The aim of this study was to investigate the expression levels of TRP channel genes in patients with glioblastoma multiforme and to evaluate the relationship between TRP gene expressions and survival of the patients. Thirty-three patients diagnosed with glioblastoma were enrolled to the study. The expression levels of 21 TRP genes were quantified by using qRT-PCR with dynamic array 48 × 48 chip (BioMark HD System, Fluidigm, South San Francisco, CA, USA). TRPC1, TRPC6, TRPM2, TRPM3, TRPM7, TRPM8, TRPV1, and TRPV2 were found significantly higher in glioblastoma patients. Moreover, there was a significant relationship between the overexpression of TRP genes and the survival of the patients. These results demonstrate for the first time that TRP channels contribute to the progression and survival of the glioblastoma patients.
Collapse
Affiliation(s)
- M Alptekin
- Department of Neurosurgery, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - S Eroglu
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - E Tutar
- Department of Pathology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - S Sencan
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - M A Geyik
- Department of Neurosurgery, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - M Ulasli
- Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - A T Demiryurek
- Department of Pharmacology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey
| | - C Camci
- Department of Medical Oncology, Faculty of Medicine, University of Gaziantep, Gaziantep, 27310, Turkey.
| |
Collapse
|
8
|
Camci C, Ergun S, Temiz E, Kirkbes S, Ulasli M, Oztuzcu S. Advancing Apoptosis by MIR-122-5P in Combination with Trastuzumab in SKBR3 Cell Line. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu467.7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
9
|
Kirkil C, Aygen E, Doğru O, Ilhan YS, Ayten R, Camci C, Göğebakan O. The efficiency of various doses of topical isosorbide dinitrate in the treatment of chronic anal fissure and the long-term results: a prospective, randomized and controlled clinical trial. Turk J Gastroenterol 2012; 23:28-32. [PMID: 22505376 DOI: 10.4318/tjg.2012.0363] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND/AIMS In recent years, numerous studies have reported that the application of topical isosorbide dinitrate can cause fissure recovery with the relaxation of the internal anal sphincter. However, there is no consensus about the dose or duration of the drugs to be applied. In addition, long-term results of the patients with chronic anal fissure treated with nitrate-containing compounds are unknown. In this study, the goal was to investigate the effects of various doses of isosorbide dinitrate on chronic anal fissure and their long-term effects. METHODS Seventy-five sequential patients with chronic anal fissure were divided into three groups. Only symptomatic treatments were applied to patients in the first group (n=15). The patients in second and third groups (n=30 each) were treated with topical isosorbide dinitrate 5% and 10%, respectively. The patients were examined three times at 20-day intervals. Five years later, 44 patients who were responsive to treatment were contacted by telephone. RESULTS The rate of full response in the 10% isosorbide dinitrate group was statistically higher than of the 5% isosorbide dinitrate group on the 20th day (53.3% vs. 26.7%, p<0.05). However, the rate of full response did not differ between these groups on the 40th and 60th days (63.3% and 70% vs. 56.7% and 63.3%, p>0.05). Five years later, 52.3% of patients who were responsive to treatment had a symptomatic relapse. CONCLUSIONS Topical isosorbide dinitrate is a good alternative therapy to protect internal anal sphincter in the treatment of chronic anal fissure. However, the recurrence rates are high in the long-term.
Collapse
Affiliation(s)
- Cüneyt Kirkil
- Department of General Surgery, Fırat University, School of Medicine, Elazığ, Turkey.
| | | | | | | | | | | | | |
Collapse
|
10
|
Arikanoglu Z, Aygen E, Camci C, Akbulut S, Basbug M, Dogru O, Cetinkaya Z, Kirkil C. Pneumatosis cystoides intestinalis: A single center experience. World J Gastroenterol 2012; 18:453-7. [PMID: 22346251 PMCID: PMC3270504 DOI: 10.3748/wjg.v18.i5.453] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/25/2011] [Revised: 08/25/2011] [Accepted: 08/31/2011] [Indexed: 02/06/2023] Open
Abstract
AIM: To share our experience of the management and outcomes of patients with pneumatosis cystoides intestinalis (PCI).
METHODS: The charts of seven patients who underwent surgery for PCI between 2001 and 2009 were reviewed retrospectively. Clinical features, diagnoses and surgical interventions of patients with PCI are discussed.
RESULTS: Seven patients with PCI (3 males, 4 females; mean age, 50 ± 16.1 years; range, 29-74 years) were analyzed. In three of the patients, abdominal pain was the only complaint, whereas additional vomiting and/or constipation occurred in four. Leukocytosis was detected in four patients, whereas it was within normal limits in three. Subdiaphragmatic free air was observed radiologically in four patients but not in three. Six of the patients underwent an applied laparotomy, whereas one underwent an applied explorative laparoscopy. PCI localized to the small intestine only was detected in four patients, whereas it was localized to the small intestine and the colon in three. Three patients underwent a partial small intestine resection and four did not after PCI was diagnosed. Five patients were diagnosed with secondary PCI and two with primary PCI when the surgical findings and medical history were assessed together. Gastric atony developed in one case only, as a complication during a postoperative follow-up of 5-14 d.
CONCLUSION: Although rare, PCI should be considered in the differential diagnosis of acute abdomen. Diagnostic laparoscopy and preoperative radiological tests, including computed tomography, play an important role in confirming the diagnosis.
Collapse
|
11
|
Gürakar A, Wright H, Camci C, Jaboour N. The application of SpyScope® technology in evaluation of pre and post liver transplant biliary problems. Turk J Gastroenterol 2011; 21:428-32. [PMID: 21331998 DOI: 10.4318/tjg.2010.0131] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
BACKGROUND/AIMS Peroral cholangioscopy with its limitations led to further research regarding development of SpyScope® technology. The aim of this retrospective study was to investigate the efficacy of a new device and the application of this device in our Liver Transplant Center. METHODS Charts of patients who had undergone evaluation with SpyScope® were retrospectively reviewed. Indications included pre-transplant as well as post-transplant evaluation of biliary strictures. If strictures or filling defects were noted by cholangiogram, SpyScope® was performed. Biopsy was obtained under direct visualization if necessary with SpyBite® biopsy forceps. Demographic features, indications for SpyScope® evaluation, results, and histopathological diagnoses were recorded. RESULTS Ten patients (6 male, 4 female; median age: 55) had undergone SpyScope® procedure between August 2007 and January 2008. Six out of 10 cases were in the pre-transplant work-up period, referred to as Group I, while the remaining four were post-transplant patients, referred to as Group II. In Group I, 4 of 6 cases had undergone the procedure for work-up of primary sclerosing cholangitis prior to orthotopic liver transplantation. In Group II, indications were either strictures noted during the previous endoscopic retrograde cholangiopancreatography (n=2) or common bile duct stones with elevated total bilirubin levels and stones with long segment biliary stricture (n=2). In the patient with anastomotic stricture, the biliary lithiasis was eventually exposed just above the anastomotic stricture, after abundant lavage was applied at that level. All SpyBite® biopsy specimens were reported to be adequate samples for histopathological examination. No malignancy was detected among 4 patients with primary sclerosing cholangitis and patients with elevated CA 19-9. CONCLUSIONS SpyScope® allows direct visualization of biliary strictures and SpyScope®/SpyBite® were found to be technically superior to conventional cholangiogram with better sampling than brushing obtained by endoscopic retrograde cholangiopancreatography. Prospective, multicenter, large volume studies are warranted to identify its sensitivity and specificity.
Collapse
Affiliation(s)
- Ahmet Gürakar
- Integris Baptist Medical Center, Nazih Zuhdi Transplant Institute, Oklahoma City, USA
| | | | | | | |
Collapse
|
12
|
Akbulut H, Altundag MK, Saip P, Coskun HS, Camci C, Ozkan M, Paydas S, Zengin N, Alco G, Aliustaoglu M, Basaran G, Yamac D, Yucel I, Goker E, Yaman E, Isikdogan A, Ozisik YY, Topuz E, Ozdogan M, Icli F. The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e12007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
13
|
Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S. Bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer: Updated findings from a randomized, multicenter phase III trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.3579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
14
|
Yalcin S, Uslu R, Dane F, Yilmaz U, Zengin N, Buyukunal E, Buyukberber S, Camci C, Sencan O, Kilickap S. A randomized, multicenter phase III trial of bevacizumab plus capecitabine as maintenance treatment after initial treatment with bevacizumab plus XELOX in previously untreated metastatic colorectal cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.474] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
474 Background: Colorectal cancer is one of the most frequent malignancies, second to breast cancer in women and third to lung cancer and prostate cancer in men. The aim of this study in first-line metastatic colorectal cancer (mCRC) was to achieve a better progression-free survival (PFS) and less risk of toxicity by administrating bevacizumab (BEV) + capecitabine + oxaliplatin (XELOX) for 6 cycles, stop oxaliplatin and go with maintenance therapy (BEV + capecitabine) until progression. Methods: BEV (7.5 mg/kg) + XELOX (capecitabine 1,000 mg/m2 bid d1–14 + oxaliplatin 130 mg/m2 d1 q3w) were administered until progression (Arm A) or 6 cycles of BEV + XELOX followed by BEV + capecitabine were administered until progression (Arm B). PFS was the primary endpoint; secondary endpoints included overall survival (OS), objective response rate (ORR), and safety. A sample size of 118 patients (pts) was calculated to achieve 80% power to detect an increase of 1.5 months in median PFS between Arm A (9.5 months) and Arm B (11.0 months) with a standard deviation of 3.9 months and significance level of 0.05 using a 10% drop-out rate. Results: A total of 122 pts were randomized. No significant differences were found in demographic characteristics between the two arms. Median treatment period was 6.1 (range 0.7–13.4) and 6.8 (range 0.7–12.4) months in Arms A and B, respectively. Interim analysis showed no statistically significant differences in median PFS and ORR between arms (see table). Tolerability was also acceptable in both arms with grade 3/4 diarrhoea in 7.7% vs. 8.2%, weakness in 15.2% vs. 8.4%, hand-foot syndrome in 6.3% vs. 9.4%, and neuropathy in 2.8% vs. 4.6% of pts in Arms A and B, respectively. Conclusions: BEV + capecitabine as maintenance therapy following induction BEV + XELOX is non-inferior to continuous BEV + XELOX until progression. While this study is ongoing, these interim findings suggest that maintenance therapy with BEV + capecitabine is an appropriate option following induction BEV + XELOX in pts with mCRC. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- S. Yalcin
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - R. Uslu
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - F. Dane
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - U. Yilmaz
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - N. Zengin
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - E. Buyukunal
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - S. Buyukberber
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - C. Camci
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - O. Sencan
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| | - S. Kilickap
- Hacettepe University Hospital, Ankara, Turkey; Ege University Hospital, Izmir, Turkey; Marmara University Hospital, Istanbul, Turkey; Dokuz Eylul University Hospital, Izmir, Turkey; Ankara Numune Research Hospital, Ankara, Turkey; Istanbul University Cerrahpasa Medical Faculty Hospital, Istanbul, Turkey; Gazi University Hospital, Ankara, Turkey; Gaziantep University Hospital, Gaziantep, Turkey; Ankara University Hospital, Ankara, Turkey
| |
Collapse
|
15
|
Aykan N, Demir G, Disci R, Yalcin S, Turhal NS, Ozdogan M, Ozkan M, Yaren A, Camci C, Akbulut H. Profile of the colorectal (CRC) cancer (Ca) patients (PTS) in Turkey: A cross-sectional disease registry study—A Turkish Oncology Group trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.4_suppl.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
394 Background: CRC Ca is one of the most common Ca worldwide. This study was designed to determine the profile of recently diagnosed CRC Ca pts in Turkey. Methods: In this national, multicenter cross-sectional disease registry study, data for 968 pts diagnosed CRC Ca were analyzed. This non-interventional study was supported by sanofi-aventis. Results: From October 2008 to October 2009, 662 colon (68%), 306 rectum (32%) Ca pts were registered from 21 centers in 7 geographic regions of Turkey. Characteristics are as follows. Male 61%, mean age was 60±12 for colon and 57±13 for rectum Ca. The ratio of colon and rectum Ca were equal in the Black Sea region, colon Ca was higher in the other 5 regions except Eastern Anatolia where the highest percentage of rectum Ca was observed (55% vs 45%). Red meat consumption was significantly high only in Eastern Anatolia (p<0.001). The consumption of alcohol, fruit and vegetables didn't show any difference. The percentage of smoking was slightly higher in the rectum Ca group (21% vs 16%, NS). The CRC family history was a risk factor in 7.4% colon, and in 5.6% rectum Ca pts. Among all pts, 1.5% had familial poliposis and only 0.4% had Lynch syndrome. Hypertension (29%) and diabetes mellitus (15%) were the most frequent concomitant diseases. Mean body mass index was 26 ± 4 in colon and 26 ± 5 in rectum Ca pts. Median time between the onset of symptoms and diagnosis was 3 months (mo) for colon and 4 mo for rectum Ca pts. For 46% of pts this time was longer than 4 mo. The mean weight loss in last 6 mo was slightly higher in colon Ca pts (3.9 vs 3.4 kg). Anemia was more frequent in colon Ca pts (p<0.05). Primary tumor location: sigmoid 37% for colon Ca, distal rectum 61% for rectum Ca. In total, 86% of pts were operated (88% of colon, 80% of rectum Ca). In 26% of pts emergency surgery was performed. AJCC staging at diagnosis: I-7%, II-26%, III-35%, IV-32% in colon and I-14%, II-22%, III-39%, IV:25% in rectum. Conclusions: This study showed that colon Ca was more frequent and most of the cases were operated. Data also revealed that pts were diagnosed at considerably later stages. The role of the consumption of red meat, obesity and smoking should be evaluated in larger trial in the future. [Table: see text]
Collapse
Affiliation(s)
- N. Aykan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - G. Demir
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - R. Disci
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - S. Yalcin
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - N. S. Turhal
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - M. Ozdogan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - M. Ozkan
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - A. Yaren
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - C. Camci
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | - H. Akbulut
- University of Istanbul, Istanbul, Turkey; Medical Oncology Department, Istanbul Bilim University School of Medicine, Istanbul, Turkey; Istanbul University Institute of Oncology, Istanbul, Turkey; Hacettepe University, Ankara, Turkey; Medical Oncology Department, Marmara University Hospital, Istanbul, Turkey; Department of Medical Oncology, Akdeniz University, Antalya, Turkey; Department of Medical Oncology, Erciyes University Medical Faculty, Kayseri, Turkey; Pamukkale University Denizli, Istanbul,
| | | |
Collapse
|
16
|
Basbug M, Bulbuller N, Camci C, Ayten R, Aygen E, Ozercan IH, Arikanoglu Z, Akbulut S. The effect of antivascular endothelial growth factor on the development of adhesion formation in laparotomized rats: experimental study. Gastroenterol Res Pract 2011; 2011:578691. [PMID: 21760775 PMCID: PMC3132490 DOI: 10.1155/2011/578691] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2011] [Accepted: 05/02/2011] [Indexed: 02/07/2023] Open
Abstract
Aims. This study determined the effects of a single dose of bevacizumab, an antiangiogenic recombinant monoclonal antibody that specifically targets vascular endothelial growth factor (VEGF), on adhesion formation in the rat cecal abrasion model. Methodology. Thirty female Wistar albino rats (200-224 g) were divided into three groups. All rats underwent laparotomy at which time cecal wall abrasion and abdominal wall injuries were induced. Group I (control) underwent only the abrasion procedure; Groups II and III received saline or bevacizumab intraperitoneally, respectively, following the abrasion. The rats were killed on postoperative day 7, and the severity of adhesions was evaluated, together with histopathological fibrosis parameters and immunohistochemical staining to identify the VEGF receptor. Results. The mean adhesion severity score in Groups I-III was 2.5 ± 0.52, 2.4 ± 0.69, and 0.7 ± 0.82, respectively; the score in Group III was significantly lower than that in Groups I (P < 0.001) and II (P < 0.001). In the histopathological evaluation, the mean fibrosis score in Group III was significantly lower that the scores in Groups I (P < 0.001) and II (P < 0.001). VEGF staining of the adhesion areas in Group III was significantly lower than that in Groups I (P < 0.001) and II (P < 0.001). Conclusion. Bevacizumab decreases adhesion formation following laparotomy in rats by blocking VEGF receptor occupancy.
Collapse
Affiliation(s)
- Murat Basbug
- 1Department of General Surgery, Diyarbakir Education and Research Hospital, 21400 Diyarbakir, Turkey
| | - Nurullah Bulbuller
- 2Department of General Surgery, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
| | - Cemalettin Camci
- 2Department of General Surgery, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
| | - Refik Ayten
- 2Department of General Surgery, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
| | - Erhan Aygen
- 2Department of General Surgery, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
| | - Ibrahim Hanifi Ozercan
- 3Department of Medical Pathology, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
| | - Zulfu Arikanoglu
- 1Department of General Surgery, Diyarbakir Education and Research Hospital, 21400 Diyarbakir, Turkey
| | - Sami Akbulut
- 1Department of General Surgery, Diyarbakir Education and Research Hospital, 21400 Diyarbakir, Turkey
- *Sami Akbulut:
| |
Collapse
|
17
|
Camci C, Firoiu E, Gumus M, Hurtado de Mendoza F, Chavez-Zamudio MA, Davidson N, Brychta M, Donadio M, Soldatenkova V, Benhadji KA. Factors associated with the choice of taxane monotherapy or combination in the management of advanced breast cancer: Results of an international observational study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.1132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
18
|
Kalender M, Demiryürek S, Oztuzcu S, Kizilyer A, Demiryürek A, Sevinc A, Dikilitas M, Yildiz R, Camci C. Association between the Thr431asn Polymorphism of the Rock2 Gene and Breast Cancer. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-09-3038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The objective of this study was to analyze the genotype distributions and allele frequencies for Threonine431Asparagine (Thr431Asn) and Arginine83Lysine (Arg83Lys) polymorphisms of the Rho kinase2 (ROCK2) gene among the breast cancer patients.Material and Methods: In this case-control study, 223 patients with breast cancer were recruited and divided into two groups according to metastases (n=128) and without metastases (n=95). Genomic DNA from the patients and the control cases (n=150) was analyzed by real-time PCR using a Light-Cycler.Results: Neither genotype distributions nor the allele frequencies for the Arg83Lys polymorphism showed a significant difference between the groups. Although no marked changes was observed with no metastasis group, a statistically significant association was found between the control and metastatic group for the Thr431Asn polymorphism of the ROCK2 gene. Further analysis revealed that there were marked associations of this polymorphism with bone, liver, and lung metastases. Homozygous carriers of the Thr431Thr genotype were more frequent among the metastatic patients (39.8%) than among controls (26.0%; P =0.0485). There was also an increase in Thr431 allele (60.5% in patients vs 51.7% in controls) and decrease in Asn431 allele frequencies (48.3% in control vs 39.5% in patients) in metastatic groups (P =0.0356). Progesterone and estrogen receptor negativity was more frequent among metastatic patients carrying a Thr431 allele when compared to the nonmetastatic group.Discussion: Our resulsts are the first to demonstrate that Thr431Asn polymorphism of the ROCK2 gene could be a risk factor for the metastases of the breast cancer, and may help in predicting the prognosis.
Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 3038.
Collapse
Affiliation(s)
- M. Kalender
- 1Gaziantep University Medical Faculty, Gaziantep Oncology Hospital, Turkey
| | - S. Demiryürek
- 2Gaziantep University, Medical Faculty, Gaziantep School of Health, Turkey
| | - S. Oztuzcu
- 3Gaziantep University, Medical Faculty, Turkey
| | - A. Kizilyer
- 4Gaziantep University, Medical Faculty, Turkey
| | | | - A. Sevinc
- 6Gaziantep University, Medical Faculty, Gaziantep Oncology Hospital, Turkey
| | - M. Dikilitas
- 7Erciyes University, Faculty of Medicine, Turkey
| | - R. Yildiz
- 8Gazi University, Faculty of Medicine, Turkey
| | - C. Camci
- 9Gaziantep University, Medical Faculty, Gaziantep Oncology Hospital, Turkey
| |
Collapse
|
19
|
Kalender ME, Dirier A, Sevinc A, Camci C. Depression-anxiety and quality of life and the use of complementary and alternative medicine among breast cancer patients in Turkey. Cancer Res 2009. [DOI: 10.1158/0008-5472.sabcs-3130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Abstract #3130
Purpose: Breast cancer is the most common cancer type among women. The aim of this study was to examine the association between the use of complementary and alternative medicine (CAM) and quality of life, and anxiety and depression, and demographic characteristics of Anatolian women with breast cancer.
 Methods: Quality of life was measured with European Organization for Treatment and Research of Cancer (EORTC) quality of life core questionnaire (QLQ-C30, version 3.0) and anxiety and depression was measured with Hospital Anxiety and Depression Scale (HADS). The demographic characteristics of patients were filled by patient to a standard form.
 Results: Totally 122 patients with breast cancer were enrolled, and 50% (n=61) of patients reported that they were using CAM. The most commonly used CAM methods were stinging nettle (57%) and prayer and spiritual healing (49%). The statistical analysis showed that, there was a meaningful correlation between CAM usage and education level (p=0.031) and radiotherapy (p=0.002). There was no relationship between use of CAM and patients age, time since diagnosis, stage of cancer, chemotherapy using, smoking and residence. Analysis of patients showed a positive correlation between CAM and RF2 (Role Functioning) (p=0.014) and FI (Financial Difficulties) (p=0.011) and negative correlation between CAM and EF (Emotional Functioning) (p=0.033). There was no correlation between use of CAM and anxiety and depression scale. The RF2 (p=0.02), EF (p=0.047), FA (Fatigue) (p=0.038), PA (Pain) (p=0.043) and depression results (p=0.008) were better at patients with high education level. We analysed CAM using in patients living in rural or urban area, and the EF (p=0.006), CF (Cognitive Functioning) (p=0.027), PA (p=0.025), DY (Dyspnoea) (p=0.045) and DI (Diarrhoea) (p=0.000) results were better in urban area.
 Conclusions: According to the various studies in the literature, 20-83.3% of breast cancer patients were using CAM and the CAM methods are different in different countries and cultures. Our results suggest that the use of CAM among Anatolian women with breast cancer is popular. This study findings showed no correlation between anxiety and depression and CAM usage. There is a tendency to CAM usage in patients with financial problems. Emotional functioning was also worse in those patients. The study results showed that the use of CAM is more common among breast patients with bad emotional status and poor financial status.
Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 3130.
Collapse
Affiliation(s)
- ME Kalender
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| | - A Dirier
- 2 Gaziantep University Medicine School, Radiation Oncology, Gaziantep, Turkey
| | - A Sevinc
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| | - C Camci
- 1 Gaziantep University Medicine School, Medical Oncology, Gaziantep, Turkey
| |
Collapse
|
20
|
Camci C, Gurakar A, Kanoski M, Sharma S, Kanagala R, Monlux R, Wright H, Jabbour N. Nutritional effects of transjugular intrahepatic portosystemic shunt--an often neglected benefit? "A preliminary report". J Okla State Med Assoc 2009; 102:10-11. [PMID: 19271637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) is a useful procedure for preventing complications of portal hypertension. Nutritional effects of TIPS have been described in cirrhotics. In this prospective study, the nutritional effects of TIPS in cirrhotics were aimed to be identified. BMI, anthropometric measurements, laboratory parameters and Chronic liverdisease quality of life score were measured at baseline, three and six moths following TIPS placement. Total of 12 patients (6 male, 6 female; mean age 56 years; range 41-80) were enrolled between March 2002 and June 2004. Mean baseline MELD score was 13. Only 6 out of 12 patients were able to complete the study due to several reasons. BMI increased from 21.4 to 25.5. Estimated muscle mass improved from 16.6 to 20.5 (p < 0.05). Mean serum albumin improved from 2.46 to 2.76. CLDQL score improved from 103 to 150 (p < 0.05). This small study suggests potential nutritional benefits of TIPS.
Collapse
|
21
|
Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update. ACTA ACUST UNITED AC 2008; 15:570-80. [PMID: 18987925 DOI: 10.1007/s00534-008-1350-x] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2007] [Accepted: 02/20/2008] [Indexed: 12/17/2022]
Abstract
Approximately 50%-60% of patients with colorectal cancers will develop liver lesions in their life span. Despite the potential of surgical resection to provide long-term survival in this subset of patients, only 15%-20% are found to be resectable. The introduction of new neoadjuvant chemotherapeutic agents and the expanding criteria of resection have enhanced the overall 5-year survival from 30% to 60% in the past decade. The use of technical innovations such as staged resection; portal vein embolization, and repeat resection have allowed higher resection rates in patients with bilobar disease. Extrahepatic primary and liver-exclusive recurrent disease no longer represent an absolute contraindication to resection. The role of regional therapy using hepatic arterial infusion is being redefined for liver-exclusive unresectable disease. Adjuvant chemotherapy in combination with regional therapies is being looked at from fresh perspectives. Ablative approaches have gained a firm role both as an adjunct to surgical resection and in the management of patients who are not surgical candidates. Overall, the management of hepatic metastasis from colorectal cancers requires a multimodal approach.
Collapse
Affiliation(s)
- Sharad Sharma
- Nazih Zuhdi Transplant Institute, 3300 North West Expressway, Oklahoma, OK 73112, USA
| | | | | |
Collapse
|
22
|
Alacacioglu A, Somali I, Simsek I, Astarcioglu I, Ozkan M, Camci C, Alkis N, Karaoglu A, Tarhan O, Unek T, Yilmaz U. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Jpn J Clin Oncol 2008; 38:683-8. [PMID: 18753360 DOI: 10.1093/jjco/hyn082] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVE Hepatocellular cancer (HCC) is one of the important health problems in Turkey. We aimed to determine the clinical and demographic features of HCC in the Turkish population and to evaluate the prognostic and survival features. METHOD Two hundred and twenty-one patients with HCC from five hospitals in Turkey are included in this study. RESULTS In 44.4% of the 221 patients with hepatitis B virus and in 21.3% of the 221 patients with hepatitis C virus were found to be responsible for HCC etiology. It has been shown that HCC developed on cirrhosis basis in 74.2% of the patients. HCC was presented with single solitary nodule in 69.2% of the patients. Non-liver metastasis was present in 12.5% of the patients. In 21.7% of the patients, alpha-fetoprotein (AFP) levels were above the diagnostics level of 400 ng/ml. The median overall survival (OS) of 221 patients was 14 months. The median OS of the patients with Child-Pugh A class was significantly longer than that with Child-Pugh B and C classes. The OS of the individuals with normal AFP levels was also longer than that with high AFP levels. The OS of the patients with Stage I HCC according to tumor node metastasis (TNM) classification, the female patients and the treated patients group was found to be significantly good. CONCLUSIONS In conclusion, the viral etiology (hepatitis B and C infections) in Turkish population is found to be an important factor in HCC development. The Child-Pugh classification, AFP levels, TNM classification, being female and treatment were determined to be important prognostic factors in HCC patients.
Collapse
Affiliation(s)
- Ahmet Alacacioglu
- Dokuz Eylul University, Institute of Oncology, Balcova, Izmir, Turkey
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Sevinc A, Camci C, Sari I, Kalender ME, Er O, Soyuer I, Dikilitas M, Yılmaz U, Sagol O, Alacacioglu A. Cyclooxygenase-2 expression in gastrointestinal stromal tumours. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.15643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
24
|
Buyukberber S, Sari I, Camci C, Buyukberber NM, Sevinc A, Turk HM. Adrenomedullin expression does not correlate with survival in lung cancer. Med Oncol 2007; 24:245-9. [PMID: 17848751 DOI: 10.1007/bf02698047] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2006] [Revised: 11/30/1999] [Accepted: 12/16/2006] [Indexed: 11/27/2022]
Abstract
It is suggested that adrenomedullin (AM) plays a role in lung carcinogenesis although, to confirm this suggestion, further clinical studies are needed to determine its relationship with prognosis in lung cancer. Archived 50 paraffin-embedded tumor samples of the lung were retrospectively evaluated for AM expression by immunohistochemistry and analyzed for a possible correlation with patient characteristics and survival. Quantitation of immunoreactivity was accomplished using an immunohistochemical scoring system. The pulmonary resection specimens contained 22 squamous cell carcinomas, 15 adenocarcinomas, and 13 small cell carcinomas. Non-small cell carcinomas of the lung were more likely to express AM than small cell carcinomas of the lung. Ninety-one percent of squamous cell carcinomas and 87% of adenocarcinomas expressed AM at a moderate to strong level and grade2-4 (30-100%), which were significantly higher from the non-neo-plastic lung tissue. Twenty-three percent of small cell carcinomas of lung expressed AM. Interestingly, AM immunoreactivity was essentially weak and grade 1 (<%30) in this group. AM expression is upregulated in non-small cell carcinomas of the lung, whereas it is downregulated in small cell carcinomas and non-neo-plastic lung tissues. AM expression did not show any correlation with the differentiation of the tumor, the stage of cancer, and the overall survival of patients. These results did not support the role of adrenomedullin as an independent survival factor for lung cancer. However, AM inhibition in conjunction with other anti-angiogenic agents may be useful in the prevention and treatment of malignancies.
Collapse
Affiliation(s)
- S Buyukberber
- Department of Medical Oncology, Gazi University, Medical Faculty, Gazi Hospital, Ankara, 06500.
| | | | | | | | | | | |
Collapse
|
25
|
Camci C, Gurakar A, Kohli V, Sharma S, Jabbour N. Unusual presentation of recurrent hepatocellular carcinoma as obstructive jaundice 15 years after liver transplant. EXP CLIN TRANSPLANT 2007; 5:713-715. [PMID: 18194129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Hepatocellular carcinoma recurrence is a known limitation of liver transplant. Recurrence rates have been reported in 10% to 60% of patients within an average of 1 to 2 years following liver transplant. We report a case of recurrent hepatocellular carcinoma 15 years after orthotopic liver transplant, presenting initially as obstructive bile duct compression as detected by cholangiogram. Laparotomy revealed hepatocellular carcinoma invading the common bile duct without any mass in the liver parenchyma. The main focus of the case is the endoscopic retrograde cholangiopancreatography image, which is unique in the setting of liver disease following liver transplant.
Collapse
Affiliation(s)
- Cemalettin Camci
- Nazih Zuhdi Transplant Institute, Integris Baptist Medical Center, Oklahoma City, OK, USA
| | | | | | | | | |
Collapse
|
26
|
Rizvi S, Camci C, Yong Y, Parker G, Shrago S, Stokes K, Wright H, Sebastian A, Gurakar A. Is post-Lipiodol CT better than i.v. contrast CT scan for early detection of HCC? A single liver transplant center experience. Transplant Proc 2007; 38:2993-5. [PMID: 17112883 DOI: 10.1016/j.transproceed.2006.08.125] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2006] [Indexed: 11/29/2022]
Abstract
Hepatocellular carcinoma is a highly vascular neoplasm usually arising from a cirrhotic liver. Delayed, noncontrast, computed tomography (CT) imaging after 7 to 14 days reveals an oil-based contrast agent to be concentrated in the tumor but not in normal hepatic parenchyma. The aim of this study was to retrospectively correlate the post Lipiodol CT scan findings with respect to tumor size in the explanted liver. We retrospectively reviewed adult patients who had undergone orthotopic liver transplantation between November 1995 and December 2004 and also had an hepatic arteriogram with Lipiodol injection as part of their pretransplant workup. We calculated sensitivity, specificity, false-negativity, false-positivity, and accuracy of the test, as well as positive and negative predictive values. Lipiodol CT exam had sensitivity of 1.0; specificity of 0.6 with a calculated positive predictive value of 0.89 and a negative predictive value of 1.0. Overall accuracy of Lipiodol CT scan test was found to be 0.91, which was superior to an intravenous contrast CT alone. In conclusion, because of the higher sensitivity and accuracy values, hepatic arterial Lipiodol injection can be considered during the pretransplantation workup of high-risk cirrhotic patients, since the current model for End-stage Liver Disease scoring system for hepatocellular carcinoma is built on the ultimate bulk of the tumor. Further multicenter, controlled, large-volume prospective studies are warranted to verify this observation.
Collapse
Affiliation(s)
- S Rizvi
- Section of Gastroenterology, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Yilmaz M, Camci C, Sari I, Okan V, Sevinc A, Onat AM, Buyukhatipoglu H. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto's disease) mimicking systemic lupus erythematosus: a review of two cases. Lupus 2007; 15:384-7. [PMID: 16830886 DOI: 10.1191/0961203306lu2320cr] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Kikuchi-Fujimoto's disease (KFD), or histiocytic necrotizing lymphadenitis, is a benign and self-limited lymphadenitis commonly found in young women. It often shares clinical features with systemic lupus erythematosus (SLE), such as arthralgias, fever and leukopenia. The etiology of KFD remains unknown and controversial. Clinical course is favorable, with spontaneous remission in less than four months in almost all cases. Herein, we present two cases. The former is a 53-year old woman presenting with cervical lymphadenopathy, arthralgia, pancytopenia and positive antinuclear antibody (ANA). Lymph node biopsy revealed histopathological features compatible with Kikuchi-Fujimoto histiocytic necrotizing lymphadenitis. The latter patient was a 20-year old woman presenting with left cervical lympadenopathy, a butterfly rash that was reminiscent of SLE, and a positive antinuclear antibody. Based upon clinical, histological and laboratory findings, the diagnosis of SLE was excluded. Careful attention should be paid to differentiating between KFD and SLE, because of their similar presentations, yet different clinical courses and therapeutic requirements.
Collapse
Affiliation(s)
- M Yilmaz
- Department of Hematology, Gaziantep University, School of Medicine, Gaziantep, Turkey
| | | | | | | | | | | | | |
Collapse
|
28
|
Akdogan M, Camci C, Gurakar A, Gilcher R, Alamian S, Wright H, Nour B, Sebastian A. The effect of total plasma exchange on fulminant hepatic failure. J Clin Apher 2006; 21:96-9. [PMID: 16142721 DOI: 10.1002/jca.20064] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Total plasma exchange (TPE) corrects coagulopathy in patients with liver disease and removes hepatotoxins/cytokines. This improvement is transient but can be used as a bridge until an organ is identified for liver transplantation (LTx) or the liver itself regenerates. Our aim was to retrospectively assess the efficacy of TPE in fulminant hepatic failure (FHF) and its impact on liver function tests. Between 1995-2001, 39 patients with FHF who had undergone TPE were reviewed. FHF was defined according to the O'Grady criteria based on the duration of encephalopathy as well as jaundice. TPE was performed using the Cobe Spectra TPE (Gambro) in Liver Intensive Care Unit, continued on a daily basis, until either adequate clinical response was achieved, the patient expired, or transplantation occurred. INR, PTT, Fibrinogen, ALT, AST, GGT, BUN, Ammonia, and Total Bilirubin were analyzed before and after TPE. Student's t-test and chi-square test and ANOVA were used for statistical analysis. Thirty-nine patients with FHF (31 females, 8 males with mean age of 32.3, range: 7-64) underwent TPE. Coagulopathy, hyperbilirubinemia, hyperammonemia were significantly improved (P < 0.05). Twenty-one patients survived (54%), 12 required LTx, and 18 patients (including one after LTx) expired. TPE was found to be significantly effective for correction of coagulopathy and improvement of liver tests. This intervention can be considered for temporary liver support until recovery or liver transplantation.
Collapse
Affiliation(s)
- M Akdogan
- Nazih Zuhdi Transplant Institute, INTEGRIS Baptist Medical Center, Oklahoma City, OK 73120, USA
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Buyukhatipoglu H, Sevinc A, Camci C, Buyukberber S, Sari I. A case representing coexistence of acute myeloblastic leukemia and dedifferentiated liposarcoma: the possible role of chemotherapy in triggering dedifferentiation. ACTA ACUST UNITED AC 2006; 28:343-6. [PMID: 16999727 DOI: 10.1111/j.1365-2257.2006.00806.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Acute myelogenous leukemia (AML) is a hematological disorder that is characterized by an abnormal proliferation of immature myeloid cells. Dedifferentiated and well-differentiated liposarcomas are the two pathological subtypes of liposarcoma, based on the WHO classification. Transition from well-differentiated to dedifferentiated liposarcoma is a well-recognized phenomenon. Well-differentiated tumors are known to have low malignancy grade. However, when dedifferentiation occurs, the tumor acquires the aggressive features of a fully malignant lesion. This process largely is believed to progress in a time-dependant manner; however, time is not the only factor of importance. The potential roles of other factors in this transition are still unclear. To date, the coexistence of AML and liposarcoma has not been reported in the literature. In this paper, we report on a case of coexistence of AML and liposarcoma, and on the unusual behavior of a well-differentiated tumor after dedifferentiation occurs.
Collapse
Affiliation(s)
- H Buyukhatipoglu
- Division of Medical Oncology, Gaziantep Oncology Hospital, Gaziantep University, Gaziantep, Turkey
| | | | | | | | | |
Collapse
|
30
|
Dogru O, Girgin M, Bulbuller N, Cetinkaya Z, Aygen E, Camci C. Comparison of Kugel and Lichtenstein operations for inguinal hernia repair: results of a prospective randomized study. World J Surg 2006; 30:346-50. [PMID: 16479339 DOI: 10.1007/s00268-005-0408-z] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
INTRODUCTION The aim of this prospective randomized clinical study was to compare the Lichtenstein hernia repair with Kugel's patch hernia repair. METHODS From September 1999 to August 2002, adult patients with inguinal hernia were randomized into two groups. Group I included patients with the Lichtenstein hernioplasty, and group II included patients with the Kugel hernioplasty. The duration of the operation, surgical findings, and postoperative complications were recorded for the patients in both groups. RESULTS A total of 139 patients (134 men, 5 women) were randomized to either group I or group II. No significant differences were observed for the duration of the operation or the complication rates between the groups during the same follow-up time (53.06 +/- 5.6 months vs. 53.41 +/- 7.11 months in groups I and II, respectively). CONCLUSIONS Kugel herniorraphy is a minimally invasive method and as safe as the Lichtenstein hernia repair technique, with similar complication rates.
Collapse
Affiliation(s)
- Osman Dogru
- Department of General Surgery, Firat University, School of Medicine, Elazig, TR-23119, Turkey.
| | | | | | | | | | | |
Collapse
|
31
|
Aladag M, Gurakar A, Camci C, Yong Y, Wright H, Nour B, Sebastian A. Compatible ABO mismatch and liver transplantation: a single center's experience. EXP CLIN TRANSPLANT 2006; 4:467-9. [PMID: 16827645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
OBJECTIVES The current shortage of suitable donor organs and clinical urgency can lead to implanting grafts from ABO-mismatched donors. One-year graft survival rates for patients in this scenario have been reported as ranging between 25% and 75% less than those for ABO-identical or ABOcompatible grafts. We review and compare our experiences with transplanting ABO-identical and ABO-compatible mismatched livers. MATERIALS AND METHODS Considering orthotopic liver transplantation (OLTx), 520 were performed at our institution between November 1992 and May 2003, 55 of which were ABO-compatible mismatched transplants. We retrospectively reviewed the data and compared patient and graft survival rates. RESULTS Overall 1-month and 1-, 5-, and 10-year patient survival rates among identical (group 1) and mismatched (group 2) groups were 97% and 91%, 90%, and 88.5%, and 79%, and 74%, 66%, and 65%, respectively. No significant difference existed between the 2 groups (P>.05). Similarly, 1-month, and 1-, 5-, and 10-year graft survival rates among groups 1 and 2 were 96% and 87%, 89% and 83%, 78% and 71% and 66% and 59%, respectively; these were not significant either (P>.05). All of the patients in the mismatched group had a high status according to the United Network for Organ Sharing (UNOS). Only 1 person received an incompatible mismatched graft (B to A), which subsequently developed primary nonfunction. CONCLUSIONS ABO-compatible mismatch OLTx is unavoidable given the current state of organ shortage. Our results suggest that this type of OLTx can be performed with minimal risk among patients who require urgent transplantation and have high rankings according to the UNOS and the model for end-stage liver disease (MELD) system.
Collapse
Affiliation(s)
- Murat Aladag
- Nazih Zuhdi Transplantation Institute, Liver Transplant Division, Integris Baptist Medical Center, Oklahoma City, OK 73112, USA.
| | | | | | | | | | | | | |
Collapse
|
32
|
Camci C, Gurakar A, Rose J, Rizvi S, Wright H, Bader T, Monlux R, Schade RR, Nour BM, Sebastian A. Liver transplantation for hepatitis B in the United States. Transplant Proc 2006; 37:4350-3. [PMID: 16387118 DOI: 10.1016/j.transproceed.2005.10.017] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2005] [Indexed: 01/08/2023]
Abstract
AIM To evaluate the impact of hepatitis B virus (HBV) on US health care system, we reviewed the Organ Procurement and Transplantation (OPTN, formerly UNOS) HBV database. METHOD We reviewed records of liver transplantations (LTx) performed in the United States listed for the diagnoses of HBV between 1993 and mid-October 2004. Both acute as well as chronic cases were included. Coinfection with hepatitis C virus was excluded from study. The specific states selected for review were chosen from those areas that are receiving large numbers of new immigrants from high HBV endemic areas (ie, Texas, Pennsylvania, California, New York, and Florida). One-, 3-, and 5-year patient survival rates for both cadaveric and living related donors were analyzed. Survival rates were obtained from OPTN database as Kaplan-Meyer survival test. RESULTS Between 1993 and mid-October 2004, 53,312 LTx had been performed nationwide. Of these, 2314 (4.34%) were performed for the diagnosis of HBV; 1816 cases (78%) were due to chronic HBV infection (45 of them were living donor LTx) and 498 cases (22%) were due to HBV-induced acute liver failure (seven of them were living donor LTx). Three- and 5-year survival rates of chronic HBV-related LTx patients were better than acute HBV-related and overall LTx patients. CONCLUSION HBV is generally considered to have a minor health significance by many community gastroenterologists. With growing immigration from overseas, it may eventually have a higher impact on LTx. Therefore, it is crucial to further educate gastroenterologists and primary care physicians caring for this specific group of patients.
Collapse
Affiliation(s)
- C Camci
- Nazih Zuhdi Transplant Institute, Integris Baptist Medical Center, Oklahoma City, Oklahoma 73112, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
Gastric cancer (GCa) is still a common cause of cancer-related deaths worldwide, despite improved diagnostic and therapeutic implications. Hence, early diagnosis has critical importance. Flow cytometry reveals rapid and reproducible quantification of nuclear DNA content of disaggregated tissues and assessment of its significance in various malignant and precancerous lesions. A total of 121 patients with GCa, chronic atrophic gastritis (CAG), gastric polyps, intestinal metaplasia (IM) and gastric dysplasia and 36 healthy controls were enrolled in this study. Flow cytometric measurements of DNA ploidy, total S-phase, G2M-phase and proliferative indexes (PIs) were analysed on fresh gastric biopsy specimens obtained by gastroscopy. DNA aneuploidy was present in 43.75% of the GCas (p < 0.05). We found a DNA aneuploidy rate of 15.38% in CAG, 15.38% in IM and 25% in epithelial dysplasia. One of nine polyps had aneuploidy. None of the normal gastric mucosa samples showed aneuploidy. The controls had lower rates of total S-phase and PIs (p < 0.05). In conclusion, DNA flow cytometry may be offered as an objective diagnostic tool for early detection of malignant transformation in gastric lesions.
Collapse
Affiliation(s)
- M H Yasa
- Department of Gastroenterology, School of Medicine, Ondokuz Mayis University, Samsum, Turkey.
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
PURPOSE Although the exact pathogenesis of anal fissure is not known, hypertonicity of the internal anal sphincter might be involved in its pathogenesis as main event. To gain information about possible usefulness of the novel, smooth-muscle-relaxing drug, sildenafil, in chronic anal fissure, we investigated the effect of sildenafil citrate on acetylcholine-induced contractility of internal anal sphincter isolated from dogs. METHODS Internal anal sphincter strips were taken from German shepherd dogs and suspended in a tissue bath filled with Krebs solution at 37 degrees C (pH 7.4) continuously bubbled with 95 percent oxygen and 5 percent carbon dioxide, and isometric contractions were recorded. Contractions were evoked by 10 muM acetylcholine, and the effects of different concentrations of sildenafil citrate (0.1, 0.3, and 1 mM) on the isometric tension of each internal anal sphincter strip were examined. The statistical significance was analyzed by one-way analysis of variance. RESULTS Pretreatment with sildenafil citrate (0.1 mM) attenuated contractile response to acetylcholine (n = 3), which were significantly weak compared with the maximum contractile response to the acetylcholine alone (610 +/- 110 mg vs. 2,825.17 +/- 416 mg; n = 12; P < 0.05). Sildenafil citrate also significantly inhibited the acetylcholine-induced contractions in a dose-dependent manner when applied after. CONCLUSIONS This experimental in vitro study showed that sildenafil citrate relaxes acetylcholine stimulated contractions of isolated dog internal anal sphincter. This may be of importance for raising the possibility that sildenafil cit-rate may have future potential in the treatment of chronic anal fissure. Further studies are needed for a conclusive decision on possible usefulness of sildenafil citrate in patients with chronic anal fissure.
Collapse
Affiliation(s)
- Erhan Aygen
- Department of Surgery, Firat University School of Medicine, Elazig, Turkey
| | | | | | | | | | | | | |
Collapse
|
35
|
Camci C, Akdogan M, Gurakar A, Gilcher R, Rose J, Monlux R, Alamain S, Wright H, Sebastian A, Nour B. The impact of total plasma exchange on early allograft dysfunction. Transplant Proc 2005; 36:2567-9. [PMID: 15621091 DOI: 10.1016/j.transproceed.2004.09.071] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
INTRODUCTION Early allograft dysfunction (EAD) is a rare but serious complication encountered among patients undergoing liver transplant surgery. Total plasma exchange (TPE) in EAD has been suggested, but its role is still considered investigational. We retrospectively assessed the efficacy of TPE in EAD and its impact on other parameters of liver function. MATERIALS AND METHODS Between 1995 and 2001, 25 orthotopic liver transplant recipients developed EAD, which was defined as early postoperative prothrombin time (PT) >17 seconds, aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) >2500 IU/L, and/or the presence of hepatic encephalopathy, and development of renal failure. Daily TPE was performed using the Cobe Spectra TPE (Gambro) for 4 hours until an adequate clinical response, the patient underwent retransplantation, or the patient died. International normalizing ratio (INR), partial thromboplastin time (PTT), fibrinogen, ALT, AST, gamma-glutanyl transpeptidase (GGT), blood urea nitrogen (BUN), ammonia, and total bilirubin were analyzed before and after TPE. Student t and chi-square tests were used for statistical analysis. RESULTS Twenty-five patients with EAD included 13 females, 12 males of mean age 42.3 years (range, 1-63 years). Coagulopathy and hyperbilirubinemia significantly improved with TPE. Nineteen patients (76%) survived and 2 required retransplantation. Mean number of TPE sessions was 4.3. CONCLUSION TPE was effective to correct coagulopathy and improve liver function. These results suggest the benefit of potential temporary liver support until recovery or retransplantation, in the absence of sepsis or multi-system organ failure.
Collapse
Affiliation(s)
- C Camci
- Integris Baptist Medical Center
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Abstract
Intestinal obstruction is responsible for 3% of admissions to hospital emergency surgical departments, but it is difficult to distinguish simple obstruction from strangulation. Simple criteria for this distinction are sought. In this experimental study, procalcitonin, a known marker of bacterial inflammation, was used to detect strangulation. The predictive value of procalcitonin for small bowel strangulation was evaluated. Thirty male New Zealand rabbits (mean weight: 3.0 kg) were divided into three groups. In the first (control) group, only laparatomy was performed. In the second group, simple obstruction was created by ligating a 10-cm distal ileum segment. In the third group, distal strangulation was created by ligating a 10-cm distal ileum segment with the mesentery. Blood (1 cc) was taken from the right auricular vein of each animal for measuring the procalcitonin level. In both the control group and the simple obstruction group the procalcitonin levels were normal. In the strangulation group, elevation of procalcitonin was detected after 30 minutes, and the elevation was statistically significant at 120th minute compared with the control and simple obstruction groups. In patients with small bowel obstruction, measurement of procalcitonin levels is easy to perform and can be used in the follow-up. A more extensive clinical study is needed to evaluate the accuracy of the test as a marker.
Collapse
Affiliation(s)
- Refik Ayten
- Department of Surgery, Firat University Medical School, Firat Universitesi Firat Tip Merkezi, AD 23200, Genel Cerrahi, Elazig-Turkey.
| | | | | | | | | | | |
Collapse
|
37
|
|
38
|
Dogru O, Dogru M, Aygen E, Camci C, Kirkil C, Canbazoglu C, Sahin S. The possible contribution of 129I in the drinking water and food supply to the nodular formation of thyroid tissue. Health Phys 2005; 88:243-247. [PMID: 15706144 DOI: 10.1097/01.hp.0000149881.95454.81] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Nodular formation of the thyroid tissue can occur as a result of exposure to radiation. The nodular goiter is a common disease seen in the city of Elazig and its surroundings, in the eastern part of Turkey. A prospective study was conducted in an effort to identify the role of 129I in drinking water supply. Specimens obtained from nodular and normal thyroid tissue during surgery and also water specimens were counted by nuclear spectrometric system. 129I radioactivity in nodular tissue was noted to be higher compared to normal tissue and the difference was statistically significant (p <0.05). There was no statistically significant difference (p >0.05) between 129I radioactivity in the water supply and tissue obtained from the patients who have malignant or benign nodular lesions. These results support that the 129I radioactivity level in the water supply is one of the risk factors of the nodular formation of the thyroid tissue in the eastern part of Turkey.
Collapse
Affiliation(s)
- Osman Dogru
- Firat University, School of Medicine, Department of General Surgery, Elazig, 23200, Turkey
| | | | | | | | | | | | | |
Collapse
|
39
|
Abstract
PURPOSE The aim of this study was to determine the impact of crystallized phenol on the outpatient treatment of pilonidal disease. PATIENTS AND METHODS A retrospective analysis was undertaken of patients seen in the outpatient surgery clinic of the University Hospital, Elazlg, Turkey. Age, gender, body mass index, characteristics of sinuses at initial presentation, and the recovery time of 41 patients were analyzed. The relationship between recovery time and the number of sinus openings, presence of abscess, and status of the sinuses (acute vs. chronic) were noted. RESULTS Crystallized phenol was applied a total of 107 times on 41 patients. Seventy percent of the patients had two to three applications. Mean recovery time was 42.7 (+/- standard deviation of 24) days with a range of 13 to 120 days. Recurrences were observed in only two patients at the fifth and eighth months following recovery. The success rate was 95.1 percent. Median follow-up was 24 (range, 6-98) months. The status of sinuses (acute vs. chronic and presence or absence of abscess) and the number of sinus opening had no effect on recovery time (P > 0.005). CONCLUSION Crystallized phenol treatment is a simple and inexpensive method that can be readily applied on an outpatient basis, decreasing both the recurrence rate and lost work time. We suggest that this method be considered the first-line treatment of any type of pilonidal sinus.
Collapse
Affiliation(s)
- Osman Dogru
- Department of General Surgery, Firat University School of Medicine, Elazig, Turkey.
| | | | | | | | | |
Collapse
|
40
|
Ozdarendeli A, Camci C, Aygen E, Kirkil C, Toroman ZA, Dogru O, Doymaz MZ. SV40 in human thyroid nodules. J Clin Virol 2004; 30:337-40. [PMID: 15163424 DOI: 10.1016/j.jcv.2003.12.008] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 12/12/2003] [Accepted: 12/23/2003] [Indexed: 11/21/2022]
Abstract
BACKGROUND Simian virus 40 (SV40) has been a model experimental system for the study of cell transformation and tumorigenesis for many years. The study of SV40 in humans has aroused interest in the related BK virus (BKV) and JC virus (JCV) and their role in human disease. OBJECTIVES SV40 has been found in a variety of human samples, both malignant and normal. Many independent studies have suggested that SV40 plays a role for some cancers. However, in most cases the role of SV40 remains unclear. STUDY DESIGN The subject of this study consisted of 99 patients with thyroid nodules. Both thyroid nodule and normal thyroid tissue were taken from each patient to test whether they contained SV40 sequences. RESULTS We detected SV40 sequences by polymerase chain reaction (PCR) in four of 99 thyroid nodules. Two of them were papillary thyroid carcinomas and the others were benign thyroid nodules. No SV40 was detected in 99 of normal thyroid tissues of the same patients. DNA sequence analysis, performed in four positive samples, confirmed that PCR products belong to the SV40 T antigen (Tag) region. CONCLUSION The possible role of SV40 in the development of thyroid nodules and the spread of SV40 by horizontal infection in the human population are discussed.
Collapse
Affiliation(s)
- A Ozdarendeli
- Department of Microbiology and Clinical Microbiology, College of Medicine, Firat University, Elazig, Turkey.
| | | | | | | | | | | | | |
Collapse
|
41
|
Abstract
BACKGROUND Laparoscopic procedures are safe and effective treatment methods in experienced hands. However, complications have been reported for laparoscopic procedures. One of the complications of laparoscopic cholecystectomy is vascular injuries. Hepatic and cystic artery injuries may occur alone or in association with bile duct injury. Bleeding from arterial injury may be seen during operation or in the late postoperative period. One of the most significant pathologies leading to this rare phenomenon is hemobilia. METHODS We present a case of a 62-year-old woman who underwent routine laparoscopic cholecystectomy for cholelithiasis at another hospital. She presented 6 months later with the clinical feature of upper gastrointestinal bleeding. RESULTS There was a 42 x 40 x 11 mm anechoic lesion and an echoic pattern compatible with a metallic object was found in the subhepatic region using abdominal ultrasonography. In the endoscopic examination, fresh blood was found in the stomach. The source of hemorrhage could not be identified. Bulbus duodeni was normal but a fresh clot on the papilla of Vateri was seen on gastroduodenoscopic examination. Laparotomy was performed and the provisional diagnosis of hemobilia was reached. The injured hepatic artery and pseudoaneurysmatic structure were repaired. CONCLUSION Hemobilia is a late complication of laparoscopic cholecystectomy. We believe that it is important to take into consideration that bile duct injuries may be accompanied by arterial pathology.
Collapse
Affiliation(s)
- O Dogru
- General Surgery Department, Firat University School of Medicine, 23200 Elazig, Turkey,
| | | | | | | | | |
Collapse
|
42
|
Büyükberber N, Büyükberber S, Kadayifci A, Guney C, Camci C, Balkan A, Kubar A, Turk HM, Sevinc A. The prevalence of hepatitis G virus in cancer patients. New Microbiol 2003; 26:243-8. [PMID: 12901419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/04/2023]
Abstract
Hepatitis G virus (HGV) is transfusion-transmissible and has a global distribution. However, its frequency and clinical impact have not been well established in extrahepatic cancer patients. In this study, we determined the prevalence of HGV RNA positivity, and its relationship with history of transfusion, amount of transfusion, age and sex in patients with hematological and solid malignancies in Southeastern Turkey. Sixty-one patients (35 males and 26 females) followed up for various malignancies and 60 healthy subjects were included in the study. HGV RNA was investigated by the reverse transcription polymerase chain reaction. HGV RNA was detected in none of the patients with cancer (0%) and only one person (1.6%) in the control group. There was no difference between the groups. This observation indicates that the prevalence of HGV is very low in cancer patients and healthy people in our geographical area. In addition, the role of HGV in the pathogenesis of extrahepatic malignancies seems insignificant.
Collapse
Affiliation(s)
- N Büyükberber
- Gaziantep University, Medical Faculty, Department of Molecular Biology, Gaziantep, Turkey
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Camci C, Büyükberber S, Tarakçioğlu M, Adam SM, Camci C, Türk HM, Büyükberber N, Balat O. The effect of continuous ambulatory peritoneal dialysis on serum CA-125 levels. EUR J GYNAECOL ONCOL 2003; 23:472-4. [PMID: 12440830] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Malignant and non-malignant serosal fluids were found to be associated with high serum levels of CA-125, suggesting that the presence of fluid in the serosal cavities may stimulate its release. In this study, we investigated the relationship between serum CA-125 levels and peritoneal irritation during continuous ambulatory peritoneal dialysis (CAPD). We performed a clinical study in 24 stable patients (15 amenstrual females and 9 males), aged 46 +/- 14 years on CAPD. The control group consisted of 32 healthy volunteers (20 females, 12 males) aged 44 +/- 12 years. CA-125 levels were determined prior to the CAPD dwell (without dialysate in abdomen) and during the CAPD dwell (dialysate in abdomen 4 hours after). As a result, serum CA-125 levels were found to be 14.86 +/- 5.98 U/ml and 15.23 +/- 6.05 U/ml respectively, whereas it was 8.32 +/- 5.54 U/ml in the control group. Serum CA-125 levels were found to be significantly elevated in CAPD patients when compared with healthy volunteers. However, serum CA-125 levels detected prior to and after CAPD did not differ between the groups. Interestingly, all of the patients in our study group were detected to have normal serum CA-125 levels (< 35 U/ml). We concluded that CAPD-induced abdominal artificial ascites did not affect serum levels of CA-125. Moreover, short and non-inflammatory mechanical pressures in the CAPD procedure do not have any effect on serum CA-125 levels.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Oncology, Adana, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Camci C, Balat O. Neoadjuvant chemotherapy in ovarian cancer. EUR J GYNAECOL ONCOL 2003; 23:437-41. [PMID: 12440820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Patients with advanced ovarian cancer have a chance of less than 50% after radical debulking surgery. In spite of the currently more effective combination chemotherapy agents that have become available as adjuvant therapy in the last decade, the prognosis of patients with residual tumor mass larger than 1 cm in diameter following surgery is still poor. Neoadjuvant or primary chemotherapy has been suggested as an alternative approach to primary laparotomy of the bulky ovarian cancer. The advantages and available data on neoadjuvant chemotherapy are discussed in this review.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Medical Oncology, Turkey
| | | |
Collapse
|
45
|
Aydin A, Kutlar I, Camci C. Ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary: a case report of unusual acute abdominal syndrome. EUR J GYNAECOL ONCOL 2002; 22:350-1. [PMID: 11766738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
Although granulosa cell tumor combined with a dermoid cyst in the same ovary is rarely seen, adult granulosa cell tumor of the ovary with contralateral teratoma has not been reported to date. In this report we present the first case in the English language literature of a ruptured granulosa cell tumor of the left ovary and mature cystic teratoma of the right ovary presenting as acute abdominal syndrome. The patient underwent total abdominal hysterectomy, bilateral-ophorectomy, and multiple pelvic lymph node sampling and infracolic omentectomy. She received combined chemotherapy consisting of bleomycin, etoposide. and cisplatin for six cycles. Subsequent follow-up and workups have revealed no evidence of disease. At 19 months after initial diagnosis, she is disease-free.
Collapse
|
46
|
Abstract
Wilms' tumor occurs rarely in adults, especially after the third decade. In adults, the prognosis of Wilms' tumor is worse than in children. In this case report, we present a 48-year old patient who relapsed with advanced stage shortly after primary surgery. A definitive treatment plan has not been established because of the rarity of this tumor in adults. After surgical removal, multimodal therapy should be begun immediately for long-lasting, complete remission.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Medical Oncology, Gaziantep, Turkey.
| | | | | | | | | | | |
Collapse
|
47
|
Camci C, Guney C, Balkan A, Buyukberber N, Buyukberber S, Kadayifci A, Kubar A. The prevalence of TT virus in cancer patients. New Microbiol 2002; 25:463-8. [PMID: 12437226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
Abstract
Transfusion-transmitted virus (TTV) is a recently discovered transfusion-transmissible DNA virus. Its frequency and clinical impact has not been established in cancer patients in Turkey. In this study, we determined the prevalence of TTV DNA positivity, and its relationship with history of transfusion, amount of transfusion, age and sex in patients with hematological and solid malignancies. Sixty-one patients (35 male and 26 female) followed up for various malignancies and 45 healthy subjects were included in the study. ITV DNA was assayed by the polymerase chain reaction (PCR). TTV DNA was detected in 18 of 61 patients (29.5%) and in 5 of 45 control subjects (11.1%). In cancer patients, the prevalence of TTV DNA positivity was higher to comparison with control group. In addition, the prevalence of TTV DNA positivity was significantly higher in 22 patients who had a history of blood transfusion in the last 6 months than 39 patients who had no current or past history of transfusion (40.9% vs 23.0% respectively). These results suggest that the prevalence of TTV DNA is high and the parenteral route is an important mode of transmission for TTV in cancer patients. In addition, the high prevalence and persistence of TTV in cancer patients with parenteral risk exposure could be related to the immunodeficiency due to cancer and high viral loads by parenteral route.
Collapse
Affiliation(s)
- C Camci
- Gaziantep University, Medical Faculty, Department of Clinical Oncology, Turkey
| | | | | | | | | | | | | |
Collapse
|
48
|
Okan V, Araz M, Camci C, Aktaran S, Sahin A, Buyukberber S, Bakir K, Cakmak EA. Bernard-Soulier syndrome in a Turkish family. Int J Clin Pract 2002; 56:546-8. [PMID: 12296619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/05/2023] Open
Abstract
This report describes the first Turkish family to be diagnosed with Bernard-Soulier syndrome. The family consists of nine members (two parents, three sons and four daughters). The parents were first cousins. The index case, a 22 year-old-man, had a history of haemorrhagic diathesis with thrombocytopenia, giant platelets in the peripheral blood smear and a prolonged bleeding time. Refractory idiopathic thrombocytopenic purpura had been diagnosed elsewhere and a splenectomy had been performed six months previously. Ristocetin agglutination of platelets was defective and flow cytometry analysis of platelet membrane glycoprotein showed markedly reduced expression of glycoprotein lb (2.1%). Bernard-Soulier syndrome was diagnosed. Increased mean platelet volume was found in both parents, one son and three daughters. The other son and daughter were normal.
Collapse
Affiliation(s)
- V Okan
- Department of Internal Medicine, University of Gaziantep, School of Medicine, Turkey
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Uzol O, Camci C. Experimental and computational visualization and frequency measurements of the jet oscillation inside a fluidic oscillator. J Vis (Tokyo) 2002. [DOI: 10.1007/bf03182334] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
Turk HM, Sevinc A, Camci C, Cigli A, Buyukberber S, Savli H, Bayraktar N. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 2002; 39:117-22. [PMID: 12357295 DOI: 10.1007/s005920200029] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Diabetes is associated with a significant increase in thiobarbituric acid reactive substances (TBARS) which are considered as an index of endogenous lipid peroxidation. The human body has a complex antioxidant defense system that prevents the initiation of free radical chain reactions. We measured plasma TBARS levels, superoxide dismutase (SOD) and catalase (CAT) activities and compared their relation to the metabolic control of diabetes and diabetic microangiopathy. Sixty-four patients (19 men), aged 52.35+/-9.31 years with type 2 diabetes mellitus were included in the study. Thirty-six healthy subjects (12 men), aged 51.02+/-7.01 years formed the control group. TBARS levels and SOD activity were elevated in the diabetic group when compared with the control group ( p<0.001 and p<0.00001, respectively). However CAT activity was significantly decreased in the diabetic group when compared with the control group ( p<0.00001). Patients with diabetic nephropathy and retinopathy, but not neuropathy, had elevated TBARS levels but there was no statistically significant difference when compared with diabetic patients without microangiopathy ( p>0.05). There was a positive correlation between plasma TBARS levels and SOD activity (r=0.770, p=0.0001) and a negative correlation between plasma TBARS levels and CAT activity (r=0.482, p=0.0001). There was also a negative correlation between SOD and CAT activities (r=-0.609, p=0.0001). We found significantly elevated TBARS levels in diabetic patients. We did not observe any correlation between TBARS levels and blood glucose and HbA(1c) levels. Elevated TBARS levels and SOD activity and decreased CAT activity may be due to a compensation mechanism of the body.
Collapse
Affiliation(s)
- H M Turk
- Department of Internal Medicine, Sahinbey Medical Center, Gaziantep University, School of Medicine, Gaziantep, Turkey
| | | | | | | | | | | | | |
Collapse
|